Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, Korea.
Department of Radiology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
Eur Radiol. 2017 Oct;27(10):4030-4036. doi: 10.1007/s00330-017-4795-y. Epub 2017 Mar 22.
We retrospectively evaluated the doubling time (DT) of thymic epithelial tumours (TET) according to the histological subtype on CT.
From January 2005 to June 2016, we enrolled 53 patients who had pathologically confirmed TET and at least two CT scans. Tumour size was measured using a two-dimensional method, and the DT was calculated. DTs were compared among histological subtypes, and factors associated with rapid tumour growth (DT <180 days) were assessed.
In 42 of the 53 patients (79.2%) the tumours showed interval growth (>2 mm) during follow-up. The median DT for all tumours was 400 days (range 48-1,964 days). There were no significant differences in DT in relation to histological subtype (p = 0.177). When TETs were recategorized into three groups, i.e. low-risk thymomas (types A, AB, B1), high-risk thymomas (types B2, B3), and thymic carcinoma, DT was significantly different among the groups (median DT 436, 381 and 189 days, respectively; p = 0.031). Histological subtype (type B3 and thymic carcinoma) was the single independent predictor of rapid tumour growth.
The majority of TETs grew during follow-up with variable and relatively slow growth rates. Histological features of aggressive behaviour significantly correlated with a decreased DT and rapid growth.
• The majority of thymic epithelial tumours grew during follow-up (79.2%, 42/53). • Doubling times of thymic epithelial tumours were highly variable (median 400 days). • Histological features of aggressive behaviour significantly correlated with a decreased doubling time.
我们根据 CT 上的组织学亚型回顾性评估胸腺瘤(TET)的倍增时间(DT)。
2005 年 1 月至 2016 年 6 月,我们纳入了 53 名经病理证实为 TET 且至少有两次 CT 扫描的患者。使用二维方法测量肿瘤大小,并计算 DT。比较不同组织学亚型之间的 DT,并评估与肿瘤快速生长(DT<180 天)相关的因素。
在 53 例患者中的 42 例(79.2%)中,肿瘤在随访期间显示出间隔生长(>2mm)。所有肿瘤的中位 DT 为 400 天(范围 48-1964 天)。组织学亚型与 DT 无显著差异(p=0.177)。当 TET 被重新分为三组,即低危胸腺瘤(A型、AB 型、B1 型)、高危胸腺瘤(B2 型、B3 型)和胸腺癌时,各组之间的 DT 存在显著差异(中位 DT 分别为 436、381 和 189 天;p=0.031)。组织学亚型(B3 型和胸腺癌)是肿瘤快速生长的唯一独立预测因素。
大多数 TET 在随访期间生长,生长速度不同且相对较慢。侵袭性行为的组织学特征与 DT 降低和快速生长显著相关。
大多数胸腺瘤在随访期间生长(79.2%,42/53)。
胸腺瘤的倍增时间高度可变(中位值 400 天)。
侵袭性行为的组织学特征与降低的倍增时间显著相关。